Education
About Us
Working with TipRanks
Follow Us
Nyxoah (NYXH)
NASDAQ:NYXH
Earnings Data
Report Date
Aug 06, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
-0.62Last Year’s EPS
-0.48Same Quarter Last Year
Strong Buy
Based on 5 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:May 14, 2025
|% Change Since: 7.79%
|Next Earnings Date:Aug 06, 2025
Earnings Call Sentiment|Neutral
The earnings call presents a balanced outlook. While Nyxoah is making significant progress towards FDA approval and preparing for a U.S. launch with innovative strategies and market entry into the Middle East, it faces challenges with a slight revenue decline, increased operating loss, and a decreased cash position.Company Guidance
During the first quarter of 2025 earnings call, Nyxoah provided guidance and updates on their path to obtaining full PMA approval for their Genio system in the United States, expecting approval by the second quarter of 2025. The FDA issued an approvable letter confirming substantial meeting of marketing requirements, with final approval pending satisfactory completion of manufacturing facilities and process validation, which has already been completed. Nyxoah is preparing for a U.S. commercial launch with a team of 50 members, aiming to scale each quarter post-FDA approval. They plan to use CPT code 64568 for reimbursement, aligning their pricing with competitors while leveraging unique technological benefits. Financially, Nyxoah reported a revenue of €1.1 million for Q1 2025, a slight decrease from €1.2 million in Q1 2024, primarily due to temporary softness in the HGNS market, while their operating loss increased to €20.6 million from €12.2 million year-over-year, driven by U.S. commercial investments. The company’s cash position stood at €63 million as of March 31, 2025.PMA Approval Progress
Nyxoah received an approvable letter from the FDA for the Genio system, confirming the application substantially meets the U.S. marketing requirements. The FDA has no further questions on the manufacturing validation, and the final on-site inspection is expected to be completed shortly.
U.S. Commercial Launch Preparations
Nyxoah has built a commercial team of 50 members in the U.S., ready to support the launch of Genio, with a strategy focused on high-volume hypoglossal nerve stimulation centers and building networks with sleep physicians.
Reimbursement and Pricing Strategy
Nyxoah plans to use the established CPT code 64568 for reimbursement, which is recognized for OSA indications, expecting pricing similar to competitors but differentiating through unique technology benefits.
Genio 2.1 Software Upgrade
The Genio 2.1 patient software upgrade has been launched, offering increased patient autonomy and comfort by allowing gradual stimulation increases and more personalized settings.
Middle East Market Entry
Nyxoah has successfully entered the Middle East market, with initial Genio implants conducted in Dubai and plans to expand to Kuwait and Saudi Arabia.
---
NYXH Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
NYXH Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 14, 2025 | $5.78 | $6.06 | +4.84% |
Mar 13, 2025 | $9.73 | $10.05 | +3.29% |
Nov 06, 2024 | $10.00 | $9.64 | -3.60% |
Aug 06, 2024 | $7.88 | $8.24 | +4.57% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Nyxoah (NYXH) report earnings?
Nyxoah (NYXH) is schdueled to report earning on Aug 06, 2025, TBA Not Confirmed.
What is Nyxoah (NYXH) earnings time?
Nyxoah (NYXH) earnings time is at Aug 06, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is NYXH EPS forecast?
NYXH EPS forecast for the fiscal quarter 2025 (Q2) is -0.62.
---